82 related articles for article (PubMed ID: 29739005)
1. Smoking Exposure in Early Pregnancy and Adverse Pregnancy Outcomes: Usefulness of Urinary Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Levels.
Lee SW; Han YJ; Cho DH; Kwak HS; Ko K; Park MH; Han JY
Gynecol Obstet Invest; 2018; 83(4):365-374. PubMed ID: 29739005
[TBL] [Abstract][Full Text] [Related]
2. [Determination of 4-(methylnirosamino) -4-(3-pyridyl)-1-butanol (NNA) in urine of pregnant women by means of LC/MS/MS].
Florek E; Piekoszewski W; Lechowicz W; Szymańska A; Kornacka MK
Przegl Lek; 2006; 63(10):926-31. PubMed ID: 17288186
[TBL] [Abstract][Full Text] [Related]
3. Fetal Exposure to Carcinogens With Tobacco Use in Pregnancy: Phase 1 MAW Study Findings.
Flanagan CA; Koller KR; Wolfe AW; Thomas TK; Benowitz NL; Renner CC; Hughes C; Hatsukami DK; Bronars C; Murphy NJ; Day G; Decker PA; Patten CA
Nicotine Tob Res; 2016 Nov; 18(11):2162-2168. PubMed ID: 27190400
[TBL] [Abstract][Full Text] [Related]
4. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
[TBL] [Abstract][Full Text] [Related]
5. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
[TBL] [Abstract][Full Text] [Related]
6. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
[TBL] [Abstract][Full Text] [Related]
7. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
[TBL] [Abstract][Full Text] [Related]
8. Assessing tobacco smoke exposure in pregnancy from self-report, urinary cotinine and NNAL: a validation study using the New Hampshire Birth Cohort Study.
Peacock JL; Palys TJ; Halchenko Y; Sayarath V; Takigawa CA; Murphy SE; Peterson LA; Baker ER; Karagas MR
BMJ Open; 2022 Feb; 12(2):e054535. PubMed ID: 35131829
[TBL] [Abstract][Full Text] [Related]
9. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
[TBL] [Abstract][Full Text] [Related]
10. Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users.
Benowitz NL; Flanagan CA; Thomas TK; Koller KR; Wolfe AW; Renner CC; Hughes C; Decker PA; Hatsukami DK; Murphy NJ; Patten C
Int J Circumpolar Health; 2018 Dec; 77(1):1528125. PubMed ID: 30325719
[TBL] [Abstract][Full Text] [Related]
11. Analysis of urinary tobacco-specific nitrosamine 4- (methylnitrosamino)1-(3-pyridyl)-1- butanol (NNAL) and HPV infection in American women: National health and nutrition examination survey.
Liang D; Zhang Q; Li W; Lin Y
PLoS One; 2024; 19(5):e0304499. PubMed ID: 38820512
[TBL] [Abstract][Full Text] [Related]
12. Association of a Tobacco-specific Nitrosamine Carcinogen with Urinary Cotinine, Urinary Sodium Excretion, and Total Energy Intake in Adolescents and Children.
Choi JW; Fujii T; Fujii N
Curr Med Sci; 2021 Apr; 41(2):270-278. PubMed ID: 33877542
[TBL] [Abstract][Full Text] [Related]
13. Children's exposure to environmental tobacco smoke: using diverse exposure metrics to document ethnic/racial differences.
Sexton K; Adgate JL; Church TR; Hecht SS; Ramachandran G; Greaves IA; Fredrickson AL; Ryan AD; Carmella SG; Geisser MS
Environ Health Perspect; 2004 Mar; 112(3):392-7. PubMed ID: 14998759
[TBL] [Abstract][Full Text] [Related]
14. Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children.
Stepanov I; Hecht SS; Duca G; Mardari I
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):7-11. PubMed ID: 16434579
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance Evaluation of the Novel Index Combining Urinary Cotinine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Smoking Status Verification and Usefulness for Trend Monitoring of Tobacco Smoking Exposure.
Lee HS
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231448
[TBL] [Abstract][Full Text] [Related]
16. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DP; Liou SH; Lin P
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3390-5. PubMed ID: 19064555
[TBL] [Abstract][Full Text] [Related]
18. Serum cotinine and urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol levels among non-Hispanic Asian American smokers and nonsmokers as compared to other race/ethnicities: data from NHANES 2011-2012.
Jain RB
Chemosphere; 2015 Feb; 120():584-91. PubMed ID: 25462301
[TBL] [Abstract][Full Text] [Related]
19. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
Joseph AM; Hecht SS; Murphy SE; Carmella SG; Le CT; Zhang Y; Han S; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2963-8. PubMed ID: 16365017
[TBL] [Abstract][Full Text] [Related]
20. Comparison of creatinine and specific gravity for hydration corrections on measurement of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
Xia Y; Wong LY; Bunker BC; Bernert JT
J Clin Lab Anal; 2014 Sep; 28(5):353-63. PubMed ID: 24648246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
